483 Document: Jiangsu Sihuan Bioengineering Pharmaceutical Co., Ltd., May 21, 2021

FDANews 483 Jiangsu Sihuan Bioengineering Pharmaceutical Co., Ltd. May 21 2021 top
Marcus A. Ray FDA Investigator

On May 21, 2021, the FDA inspected Jiangsu Sihuan Bioengineering Pharmaceutical Co., Ltd.'s Wuxi site. Explore the inspectional observations.